These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 33179733)

  • 1. A six-gene-based signature for breast cancer radiotherapy sensitivity estimation.
    Chen X; Zheng J; Zhuo ML; Zhang A; You Z
    Biosci Rep; 2020 Dec; 40(12):. PubMed ID: 33179733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A signature based on 11 autophagy genes for prognosis prediction of colorectal cancer.
    Chen S; Wang Y; Wang B; Zhang L; Su Y; Xu M; Zhang M
    PLoS One; 2021; 16(10):e0258741. PubMed ID: 34699544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and Prognostic Value Exploration of Cyclophosphamide (Cytoxan)-Centered Chemotherapy Response-Associated Genes in Breast Cancer.
    Du J; Dong Y; Li Y
    DNA Cell Biol; 2021 Nov; 40(11):1356-1368. PubMed ID: 34704810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A glycolysis-related signature to improve the current treatment and prognostic evaluation for breast cancer.
    Feng S; Ning L; Zhang H; Wang Z; Lu Y
    PeerJ; 2024; 12():e17861. PubMed ID: 39119106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and Prognostic Value Exploration of Radiotherapy Sensitivity-Associated Genes in Non-Small-Cell Lung Cancer.
    Ma Q; Geng K; Xiao P; Zeng L
    Biomed Res Int; 2021; 2021():5963868. PubMed ID: 34518802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a pyroptosis-related prognostic signature in breast cancer.
    Chen H; Luo H; Wang J; Li J; Jiang Y
    BMC Cancer; 2022 Apr; 22(1):429. PubMed ID: 35443644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioinformatic analysis and experimental validation of six cuproptosis-associated genes as a prognostic signature of breast cancer.
    Chen X; Sun H; Yang C; Wang W; Lyu W; Zou K; Zhang F; Dai Z; He X; Dong H
    PeerJ; 2024; 12():e17419. PubMed ID: 38912044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A mitochondrial function-related LncRNA signature predicts prognosis and immune microenvironment for breast cancer.
    Wang Y; Gao S; Xu Y; Tang Z; Liu S
    Sci Rep; 2023 Mar; 13(1):3918. PubMed ID: 36890266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of prognostic melatonin-related lncRNA signature in tumor immune microenvironment and drug resistance for breast cancer.
    Gao SC; Wu MD; Zhang XX; Liu YF; Wang CL
    Asian J Surg; 2023 Sep; 46(9):3529-3541. PubMed ID: 37330302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A four-gene signature in the tumor microenvironment that significantly associates with the prognosis of patients with breast cancer.
    Wang J; Yang Z; Zhang C; Ouyang J; Zhang G; Wu C
    Gene; 2020 Nov; 761():145049. PubMed ID: 32791092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ATP2C2 Has Potential to Define Tumor Microenvironment in Breast Cancer.
    Liu J; Wei Y; Wu Y; Li J; Sun J; Ren G; Li H
    Front Immunol; 2021; 12():657950. PubMed ID: 33936088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An immune cell infiltration-based immune score model predicts prognosis and chemotherapy effects in breast cancer.
    Sui S; An X; Xu C; Li Z; Hua Y; Huang G; Sui S; Long Q; Sui Y; Xiong Y; Ntim M; Guo W; Chen M; Deng W; Xiao X; Li M
    Theranostics; 2020; 10(26):11938-11949. PubMed ID: 33204321
    [No Abstract]   [Full Text] [Related]  

  • 13. A novel prognostic model based on immunogenomics for clear cell renal cell carcinoma.
    Wu Z; Shen Y; Fan D; Liu J; Chen D; Wang K; Xu X
    Int Immunopharmacol; 2021 Jan; 90():107119. PubMed ID: 33243605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
    Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
    BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A five-immune-related genes-based prognostic signature for colorectal cancer.
    Zhu L; Wang H; Wang Z
    Int Immunopharmacol; 2020 Nov; 88():106866. PubMed ID: 32781411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of the prognostic value of ferroptosis-related gene signature in breast cancer patients.
    Wang D; Wei G; Ma J; Cheng S; Jia L; Song X; Zhang M; Ju M; Wang L; Zhao L; Xin S
    BMC Cancer; 2021 May; 21(1):645. PubMed ID: 34059009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A ferroptosis-associated gene signature for the prediction of prognosis and therapeutic response in luminal-type breast carcinoma.
    Peng Y; Yu H; Zhang Y; Qu F; Tang Z; Qu C; Tian J; Zong B; Wang Y; Ren H; Liu S
    Sci Rep; 2021 Sep; 11(1):17610. PubMed ID: 34475496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysing a Novel RNA-Binding-Protein-Related Prognostic Signature Highly Expressed in Breast Cancer.
    Lan Y; Su J; Xue Y; Zeng L; Cheng X; Zeng L
    J Healthc Eng; 2021; 2021():9174055. PubMed ID: 34707800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Three-mRNA Signature Associated with Pyrimidine Metabolism for Prognosis of BRCA.
    Zhang X; Zhang Q; Xie X; Li Y; Pang Z; Yu T
    Biomed Res Int; 2022; 2022():7201963. PubMed ID: 35224098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a Transcription Factor Signature That Can Predict Breast Cancer Survival.
    Fan C; Du J; Liu N
    Comput Math Methods Med; 2021; 2021():2649123. PubMed ID: 33688372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.